|
Market Cap (17-May) $82,472,520 (825th) |
Close (30-Jun) $1.50 |
Volume (30-Jun) 19,997 |
Shortsold (12-Dec) 1,378 (0.00%) (711th) |
|
52w High $1.33 |
52w Low $1.10 |
P/E - |
EPS - |
CD3 released this announcement to the ASX on 5 October 2022, 9:46. The announcement is marked as price sensitive, and is 288 page(s) in length and 2.57MB in size.
This announcement originated from CD2.
You can view all announcements from CD3 and see how they appear on a price chart on the announcements page.
At the date of this announcement, CD3 was 0.002% short sold according to ASIC data. It was ranked the 711th most shorted stock on the ASX. It remains ranked 711th as of the latest reported data (12 December 2022).
| Other Recent Announcements from CD3 | |
|---|---|
| Appendix 3Z - Final Director's Interest Notice | 30 June 2023, 10:27 |
| Appendix 3Z - Final Director's Interest Notice | 30 June 2023, 10:25 |
| Appendix 3Z - Final Director's Interest Notice | 30 June 2023, 10:22 |
| CD3: Merger Proposal - CD Private Equity Fund Series | 5 October 2022, 9:46 |
| CD1: Merger Proposal - CD Private Equity Fund Series | 5 October 2022, 9:45 |
| Net Tangible Asset Backing & Fund Update | 14 September 2022, 16:25 |
| Fund Payment Notice | 18 August 2022, 13:38 |
You must be logged in to post a reply.
